Valeant Pharmaceuticals International (VRX): Q3 EPS of $1.15 beats by $0.02. Revenue of $884.1M...

|About: Valeant Pharmaceuticals ... (VRX)|By:, SA News Editor
Valeant Pharmaceuticals International (VRX): Q3 EPS of $1.15 beats by $0.02. Revenue of $884.1M (+47% Y/Y). (PR)